Alligator Bioscience
0.915 SEK -0.54%2 investors are following this company
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Revenue
58.11M
EBIT %
-428.46 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
ATORX
Daily low / high price
0.881 / 0.947
SEK
Market cap
694.48M SEK
Turnover
1.54M SEK
Volume
1.7M
Latest videos
Financial calendar
Interim report
2024-05-06
General meeting
2024-05-07
Interim report
2024-07-11
Interim report
2024-10-24
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Allegro Investment | 31.2 % | 31.3 % |
Roxette Photo | 8.1 % | 8.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Last day of trading in paid subscribed units (Sw. BTU) in Alligator
Sista dag för handel med BTU i Alligator
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools